Literature DB >> 8009274

Postnatal depression in Singapore women.

L P Kok1, P S Chan, S S Ratnam.   

Abstract

A longitudinal study of depressive symptomatology in 200 postnatal women using the Edinburgh Postnatal Depressive Scale showed that depressive symptomatology is mild but present in nearly all the postpartum women; however only one per cent of the women over a 6-month period had scores suggestive of a postnatal depression. None had experienced any depressive hallucinations or delusions during this period.

Entities:  

Mesh:

Year:  1994        PMID: 8009274

Source DB:  PubMed          Journal:  Singapore Med J        ISSN: 0037-5675            Impact factor:   1.858


  5 in total

1.  Complex emotions, complex problems: understanding the experiences of perinatal depression among new mothers in urban Indonesia.

Authors:  Sari Andajani-Sutjahjo; Lenore Manderson; Jill Astbury
Journal:  Cult Med Psychiatry       Date:  2007-03

Review 2.  Cross-Cultural Approach of Postpartum Depression: Manifestation, Practices Applied, Risk Factors and Therapeutic Interventions.

Authors:  Olympia Evagorou; Aikaterini Arvaniti; Maria Samakouri
Journal:  Psychiatr Q       Date:  2016-03

3.  Identifying mothers with postpartum depression early: integrating perinatal mental health care into the obstetric setting.

Authors:  Helen Chen; Jemie Wang; Ying Chia Ch'ng; Roshayati Mingoo; Theresa Lee; Julia Ong
Journal:  ISRN Obstet Gynecol       Date:  2011-09-15

4.  The Effect of Early Childhood Sexual Abuse on Mental Health Among Postpartum Women Visiting Public Health Facilities in Bahir Dar City, Ethiopia: Multicenter Study.

Authors:  Habte Belete; Eyaya Misgan; Muhabaw Shumye Mihret
Journal:  Int J Womens Health       Date:  2020-12-31

5.  Economic and Health Predictors of National Postpartum Depression Prevalence: A Systematic Review, Meta-analysis, and Meta-Regression of 291 Studies from 56 Countries.

Authors:  Jennifer Hahn-Holbrook; Taylor Cornwell-Hinrichs; Itzel Anaya
Journal:  Front Psychiatry       Date:  2018-02-01       Impact factor: 4.157

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.